In line with aforementioned results, treatment with DETA NONOate significantly increased the proportion of CD133‐positive tumour cells in NSCLC PDOs (Figure 6D), along with elevated expression of Notch1 protein (Figure 6E). This evidence concerns the gene PROM1 and non-small cell lung carcinoma.